These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience. Goldsmith I; Lip GY; Mukundan S; Rosin MD J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859 [TBL] [Abstract][Full Text] [Related]
4. [Prevention of thrombosis and thromboembolism after mitral valve bioprosthesis]. Malinovskiĭ NN; Konstantinov BA; Cherepenin LP; Dzemeshkevich SL; Ivanov AS Khirurgiia (Mosk); 1982 Nov; (11):64-8. PubMed ID: 7176405 [No Abstract] [Full Text] [Related]
5. [Haemorrhagic and thrombo-embolic complications in patients with prosthetic valves--the under-appreciated problem with no safe solutions]. Trzeciak P; Poloński L; Zembala M Kardiol Pol; 2006 Sep; 64(9):1038-42. PubMed ID: 17054041 [No Abstract] [Full Text] [Related]
10. Oral anticoagulation in patients with mechanical valve prostheses: evolving protocols with new generation devices. Cotrufo M; De Feo M; De Santo LS; Della Corte A; Scardone M; Costanza S Ital Heart J; 2005 May; 6(5):401-4. PubMed ID: 15934413 [No Abstract] [Full Text] [Related]
11. [Valvular bioprostheses and anticoagulation]. Chambaz IC; Nendaz M Rev Med Suisse; 2008 Oct; 4(175):2198-202. PubMed ID: 19024573 [TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of patients with porcine cardiac valve prostheses. Janusz MT; Jamieson WR; Allen P; Gerein AN; Miyagishima RT; Burr LH; Tutassaura H; Munro AI; Tyers GF Can J Surg; 1983 Mar; 26(2):160-2. PubMed ID: 6825007 [No Abstract] [Full Text] [Related]
13. Bioprostheses: thromboembolic events in prosthetic valves. Working Group of the European Society of Cardiology on the Evaluation of Prosthetic Valves. 15-16 December, 1983, Paris, France. Abstracts. Eur Heart J; 1983 Dec; 4 Suppl I():1-32. PubMed ID: 6667702 [No Abstract] [Full Text] [Related]
14. Thromboembolic risk and durability of the Hancock bioprosthetic cardiac valve. Oyer PE; Stinson EB; Miller DC; Jamieson SW; Mitchell RS; Shumway NE Eur Heart J; 1984 Oct; 5 Suppl D():81-5. PubMed ID: 6519106 [No Abstract] [Full Text] [Related]
15. [Echocardiography quantification of the reduction of the outlet tract of the left ventricle caused by biological prostheses in the mitral position]. Huerta D; Ojeda JL; Verdín R; López Reyes J; Paz RM; Friedland C; Guadalajara JF Arch Inst Cardiol Mex; 1982; 52(6):495-500. PubMed ID: 7159131 [No Abstract] [Full Text] [Related]
16. Pathological substrates of thrombus formation after heart valve replacement with the Hancock bioprosthesis. Thiene G; Bortolotti U; Panizzon G; Milano A; Gallucci V J Thorac Cardiovasc Surg; 1980 Sep; 80(3):414-23. PubMed ID: 7412345 [No Abstract] [Full Text] [Related]